FY24 finals came in broadly in line. The financial year and post period saw Ilika deliver on a number of big milestones in both the Stereax™ and Goliath solid-state-battery (SSB) commecialisation programs. The larger format Goliath cells for automotive EV application achieved exciting targets namely: (i) first design-freeze prototype D4/P1, (ii) energy-density parity with incumbent LiIon technology and (iii) tier-1 automotive customer-sponsored in house and importantly customer site testing of P1 prototype cells. With first customer shipments of Stereax micro solid-state batteries, and the transfer of manufacturing to US medical device market-entry and distribution specialist partner Cirtec Medical LLC on track, Ilika’s SSB technology platforms are gaining visibility in both markets. Ilika moves steadily toward commercial reality in high-growth global markets and the associated value inflection.
